J Korean Soc Ther Radiol Oncol.
2000 Mar;18(1):51-58.
Radiation-induced Apoptosis is Differentially Modulated by PTK Inhibitors K562 Cells
Abstract
-
PURPOSE: The effect of PTK inhibitors (herbimycin A and genistein) on the induction of
radiation-induce d apoptosis in Ph-positive K562 leukemia cell line was investigated.
MATERIALS AND METHODS
K562 cells in exponential growth phase were irradiated with a linear
accelerator at room temperature. For 6 MV X-ray irradiation and drug treatment, cultures were
initiated at 2x10' cells/mL. The cells were irradiated with 10 Gy. Stock solutions of herbimycin A and
genistein were prepared in dimethyl sulphoxide (DMSO). After incubation at 37C for 0-48 h, the extent of
apoptosis was determined using agarose gel electrophoresis and TUNEL assay. The progression of
cells throughth the cel l cycle after irradiation and drug treatment was also determined with flow cytometry.
Western blot analysis was used to monitor bcl-2, bcl-X and bax protein levels.
RESULTS
Treatment with
10 Gy X-irradiation did not result in the induction of apoptosis. The HMA alone (500 nM) also failed to induce
apoptosis. By contrast, incubation of K562 cells with HMA after irradiation resulted in a substantial induction
of nuclear condensation and fragmentation by agarose gel electro-phoresis and TUNEL assay. Genistein
failed to enhance the ability of X-irradiation to induce DN A fragmentation. Enhancement of apoptosis by H MA
was not attributable to downregulation of the bcl-2 or bcl-X anti-apoptotic proteins. When the cells were
irradiated and maintained with HMA, the percentage cf cells in G2/M phase decreased to 30-40% at 48 h.
On the other hand, cells exposed to 10 Gy X-irradiation alone or maintained with genistein did not show
marked cell cycle redistribution.
CONCLUSION
We have shown that nanomolar concentrations of the PTK
inhibitor HMA synergize with X-irradiation in inducing the apoptosis in Ph (+) K562 leukemia cell line.
While, genistein, a PTK inhibitor which is not selective for p2 10""'' failed to enhance the radiation induced
apoptosis in K562 cells. It is unlikely that the ability of HMA to enhance apoptosis in K562 cells is attributable
to bcl-2 family. It is plausible that the relationship between cell cycle delays and cell death is essential for
drug development based on molecular targeting designed to modify radiation-induced apoptosis.